Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vagina01:26

Vagina

40.4K
The vaginal canal is a tubular structure averaging about 10 cm in length that acts as the entryway to the female reproductive system and the passageway for menstrual flow and childbirth. The interior walls of the vagina exhibit concentric folds called rugae and are topped by an area known as the fornix, which connects with the protruding cervical portion of the uterus. This canal is comprised of an external fibrous layer, a muscular middle layer, and an inner lining with mucosal rugae, which...
40.4K
Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

4.7K
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
4.7K
External Female Genitals01:15

External Female Genitals

39.6K
The vulva encompasses the external structures of the female reproductive system. At the forefront is the monpubis, a cushion of fatty tissue atop the pubic bone. Once puberty sets in, this area typically grows hair. Extending from just behind the mons pubis are the labia majora (labia = 'lips'; majora = 'larger'), which are larger skin fs olds coated with hair. Nestled within are the labia minora (labia = 'lips'; minora = 'smaller'), which are thinner, more...
39.6K
Menopause01:28

Menopause

5.1K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
5.1K
Psychosexual Stages of Personality: Genital01:23

Psychosexual Stages of Personality: Genital

2.0K
The genital stage is the final phase of Sigmund Freud's theory of psychosexual development, beginning at puberty, around age 12. During this stage, sexual energy shifts from self-focused interests to external individuals, marking the development of mature adult sexuality. Freud saw this phase as a time of sexual reawakening, with desires directed toward others outside the family. A healthy transition into this stage, according to Freud, signifies the emergence of two key aspects of adult...
2.0K
Relationship Growth01:27

Relationship Growth

263
Interpersonal relationships progress through stages, beginning with awareness and moving toward mutuality, where emotional connections deepen. While many relationships remain at moderate levels of mutuality, deeper connections form through self-disclosure, trust, and interdependence.Self-DisclosureSelf-disclosure involves revealing personal information, starting with surface-level details and gradually progressing to more intimate content. As trust grows, individuals feel more comfortable...
263

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Elinzanetant for the Treatment of Menopausal Hot Flashes: A Plain Language Review of the OASIS-1-4 Clinical Trial Results.

Women's health (London, England)·2026
Same author

Consistency of response to rimegepant for the acute treatment of migraine among real-world users - findings from the prospective observational CONFIDENCE study.

The journal of headache and pain·2026
Same author

A retrospective cohort study comparing treatment persistence between rimegepant and lasmiditan for the acute treatment of migraine in the US.

Cephalalgia : an international journal of headache·2026
Same author

Evidence for actions of estrone distinct from those of estradiol.

The Journal of clinical endocrinology and metabolism·2026
Same author

Neuron-Enriched Extracellular Vesicle MicroRNAs Reflect Hormone-Sensitive Neural Pathway Changes from Early to Late Perimenopause.

medRxiv : the preprint server for health sciences·2026
Same author

Report of the FDA's expert panel on hormone therapy.

Menopause (New York, N.Y.)·2026

Related Experiment Video

Updated: Mar 1, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

1.1K

Relationship between changes in vulvar-vaginal atrophy and changes in sexual functioning.

JoAnn V Pinkerton1, Andrew G Bushmakin2, Barry S Komm3

  • 1University of Virginia Health System, Charlottesville, VA, United States.

Maturitas
|May 26, 2017
PubMed
Summary

Vulvar-vaginal atrophy (VVA) symptoms, especially pain during intercourse, significantly improve sexual function in postmenopausal women. Reducing VVA symptoms offers substantial benefits for quality of life.

Keywords:
Conjugated estrogens/bazedoxifeneGenitourinary syndrome of menopauseMENQOLMenopauseSexual functionVulvovaginal atrophy

More Related Videos

Tissue Processing and Isolation of Primary Fibroblasts from the Human Vagina
08:30

Tissue Processing and Isolation of Primary Fibroblasts from the Human Vagina

Published on: November 22, 2024

1.1K
Laparoscopic Oocyte Retrieval and Cryopreservation during Vaginoplasty for Treatment of Mayer-Rokitansky-Kuster-Hauser Syndrome
11:53

Laparoscopic Oocyte Retrieval and Cryopreservation during Vaginoplasty for Treatment of Mayer-Rokitansky-Kuster-Hauser Syndrome

Published on: May 10, 2022

4.4K

Related Experiment Videos

Last Updated: Mar 1, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

1.1K
Tissue Processing and Isolation of Primary Fibroblasts from the Human Vagina
08:30

Tissue Processing and Isolation of Primary Fibroblasts from the Human Vagina

Published on: November 22, 2024

1.1K
Laparoscopic Oocyte Retrieval and Cryopreservation during Vaginoplasty for Treatment of Mayer-Rokitansky-Kuster-Hauser Syndrome
11:53

Laparoscopic Oocyte Retrieval and Cryopreservation during Vaginoplasty for Treatment of Mayer-Rokitansky-Kuster-Hauser Syndrome

Published on: May 10, 2022

4.4K

Area of Science:

  • Reproductive Medicine
  • Women's Health
  • Menopause Management

Background:

  • Vulvar-vaginal atrophy (VVA), a component of genitourinary syndrome of menopause, impacts postmenopausal women's quality of life.
  • Conjugated estrogens/bazedoxifene (CE/BZA) has shown efficacy in treating VVA and improving sexual function.
  • Understanding the specific relationships between VVA symptoms, clinical markers, and sexual function is crucial for targeted treatment.

Purpose of the Study:

  • To investigate the correlation between vulvar-vaginal atrophy (VVA) symptoms and clinical parameters with sexual functioning in postmenopausal women undergoing VVA treatment.
  • To quantify the impact of specific VVA symptoms (dryness, itching/irritation, pain with intercourse) on the Menopause-specific Quality of Life (MENQOL) sexual functioning domain.

Main Methods:

  • A post hoc analysis of the 12-week SMART-3 trial data was conducted.
  • The study included 664 non-hysterectomized postmenopausal women aged 40-65 with moderate to severe VVA symptoms and vaginal pH > 5.0.
  • Repeated measures models were employed to assess the relationship between VVA symptoms, clinical parameters (vaginal pH, cell maturation index), and MENQOL sexual functioning scores.

Main Results:

  • A nearly linear relationship was observed between VVA symptom severity and sexual functioning.
  • Improvements in pain during intercourse demonstrated the largest effect size (ES=0.85) on sexual functioning (ES=0.57).
  • Reductions in dryness (ES=0.35) and itching/irritation (ES=0.27) showed smaller, though still beneficial, impacts on sexual functioning, while clinical parameter changes had minimal association.

Conclusions:

  • Vulvar-vaginal atrophy (VVA) symptoms are closely linked to sexual functioning in postmenopausal women.
  • Alleviating pain during intercourse is the most effective strategy for improving sexual function among VVA symptoms.
  • While other VVA symptoms and clinical markers also influence sexual function, their impact is less pronounced than pain reduction.